Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2175 to 2224 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2175\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 2 (26s proteasome regulatory subunit s2) (26s proteasome subunit p97) (tumor necrosis factor type 1 receptor associated protein 2) (55.11 protein). [source:swissprot;acc:q13200]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
210.209\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.808\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00671\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2176\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase plk (ec 2.7.1.-) (plk-1) (serine- threonine protein kinase 13) (stpk13). [source:swissprot;acc:p53350]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.089\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00669\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2177\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal membrane protein 2 (22 kda peroxisomal membrane protein). [source:swissprot;acc:q9nr77]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
210.961\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
209.563\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00667\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2178\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock-related 70 kda protein 2 (heat shock 70 kda protein 2). [source:swissprot;acc:p54652]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2179\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock 70 kda protein 1 (hsp70.1) (hsp70-1/hsp70-2). [source:swissprot;acc:p08107]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2180\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock cognate 71 kda protein. [source:swissprot;acc:p11142]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2181\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calreticulin precursor (crp55) (calregulin) (hacbp) (erp60). [source:swissprot;acc:p27797]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
227.117\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.62\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00664\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2182\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
twinkle; likely ortholog of mouse t7 gp4-like protein with intramitochondrial nucleoid localization. [source:refseq;acc:nm\_021830]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.062\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.624\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2183\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rabaptin, rab gtpase binding effector protein 1; rabaptin-5; neurocrescin. [source:refseq;acc:nm\_004703]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2184\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
suppressor of var1, 3-like 1. [source:refseq;acc:nm\_003171]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
211.713\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
210.318\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00663\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2185\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bag-family molecular chaperone regulator-1 (bcl-2 binding athanogene- 1) (bag-1) (glucocorticoid receptor-associated protein rap46). [source:swissprot;acc:q99933]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2186\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen synthase kinase-3 alpha (ec 2.7.1.37) (gsk-3 alpha). [source:swissprot;acc:p49840]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2187\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen synthase kinase-3 beta (ec 2.7.1.37) (gsk-3 beta). [source:swissprot;acc:p49841]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2188\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein disulfide isomerase precursor (pdi) (ec 5.3.4.1) (prolyl 4- hydroxylase beta subunit) (cellular thyroid hormone binding protein) (p55). [source:swissprot;acc:p07237]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
209.54\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
208.162\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00662\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2189\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-hydroxyanthranilate 3,4-dioxygenase (ec 1.13.11.6) (3-hao) (3-hydroxyanthranilic acid dioxygenase) (3-hydroxyanthranilate oxygenase). [source:swissprot;acc:p46952]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2190\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein-like 1; zinc-finger protein in men1 region. [source:refseq;acc:nm\_006782]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2191\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hus1 checkpoint protein; hus1 (s. pombe) checkpoint homolog; hus1+-like protein. [source:refseq;acc:nm\_004507]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2192\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hyaluronan binding protein 4; intracellular antigen detected by monoclonal antibody ki-1; intracellular hyaluronan-binding protein; chromodomain helicase dna binding protein 3 interacting protein. [source:refseq;acc:nm\_014282]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2193\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
prolyl 4-hydroxylase alpha-1 subunit precursor (ec 1.14.11.2) (4-ph alpha-1) (procollagen-proline,2-oxoglutarate-4-dioxygenase alpha-1 subunit). [source:swissprot;acc:p13674]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2194\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox prospero-like protein prox1 (prox 1). [source:swissprot;acc:q92786]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2195\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rad1 homolog isoform 1; exonuclease homolog rad1; cell cycle checkpoint protein rad1 a/b; rad1-like protein; cell cycle checkpoint protein hrad1; dna repair exonuclease (rec1); dna repair protein rad1; rad1-like dna damage checkpoint protein. [source:refseq;acc:nm\_002853]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2196\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
prolyl 4-hydroxylase alpha-2 subunit precursor (ec 1.14.11.2) (4-ph alpha-2) (procollagen-proline,2-oxoglutarate-4-dioxygenase alpha-2 subunit). [source:swissprot;acc:o15460]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2197\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquinone biosynthesis monooxgenase coq6 (ec 1.14.13.-) (cgi-10). [source:swissprot;acc:q9y2z9]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
193.787\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
195.064\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00659\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2198\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase). [source:refseq;acc:nm\_003679]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2199\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
squalene monooxygenase (ec 1.14.99.7) (squalene epoxidase) (se). [source:swissprot;acc:q14534]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2200\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
insulin gene enhancer protein isl-2 (islet-2). [source:swissprot;acc:q96a47]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
196.748\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
195.466\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00656\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2201\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
p47 protein isoform a. [source:refseq;acc:nm\_016143]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.642\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.254\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00654\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2202\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor susceptibility gene 101 protein. [source:swissprot;acc:q99816]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
195.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
194.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00652\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2203\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
symplekin. [source:swissprot;acc:q92797]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
162.741\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
163.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00651\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2204\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ruvb-like 2 (ec 3.6.1.-) (48-kda tata box-binding protein-interacting protein) (48-kda tbp-interacting protein) (tip49b) (repressing pontin 52) (reptin 52) (51 kda erythrocyte cytosolic protein) (ecp-51) (tip60-associated protein 54-beta) (tap54-beta) (cgi-46). [source:swissprot;acc:q9y230]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.377\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00649\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2205\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l22 (epstein-barr virus small rna associated protein) (eber associated protein) (eap) (heparin binding protein hbp15). [source:swissprot;acc:p35268]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
199.129\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.413\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00645\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2206\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transitional endoplasmic reticulum atpase (ter atpase) (15s mg(2+)- atpase p97 subunit) (valosin containing protein) (vcp) [contains: valosin]. [source:swissprot;acc:p55072]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.571\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.19\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2207\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sin3 associated polypeptide p30; sin3-associated polypeptide, 30kd. [source:refseq;acc:nm\_003864]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
199.129\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
200.413\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2208\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
clathrin coat assembly protein ap50 (clathrin coat associated protein ap50) (plasma membrane adaptor ap-2 50 kda protein) (ha2 50 kda subunit) (clathrin assembly protein complex 2 medium chain) (ap-2 mu 2 chain). [source:swissprot;acc:p20172]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2209\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-binding cassette, sub-family c, member 10; multidrug resistance-associated protein 7. [source:refseq;acc:nm\_033450]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2210\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysosomal alpha-mannosidase precursor (ec 3.2.1.24) (mannosidase, alpha b) (lysosomal acid alpha-mannosidase) (laman) (mannosidase alpha class 2b member 1). [source:swissprot;acc:o00754]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2211\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna polymerase i transcription factor rrn3. [source:refseq;acc:nm\_018427]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2212\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s16, mitochondrial precursor (mrp-s16) (cgi- 132). [source:swissprot;acc:q9y3d3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
224.411\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.854\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00643\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2213\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimeric dihydrodiol dehydrogenase; 3-deoxyglucosone reductase. [source:refseq;acc:nm\_014475]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
210.127\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.475\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00642\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2214\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid-binding protein, adipocyte (afabp) (adipocyte lipid-binding protein) (albp) (a-fabp). [source:swissprot;acc:p15090]\vspace{3pt}}&\multirow{11}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
221.509\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.108\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00637\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2215\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid-binding protein, epidermal (e-fabp) (psoriasis-associated fatty acid-binding protein homolog) (pa-fabp). [source:swissprot;acc:q01469]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2216\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid-binding protein, brain (b-fabp) (brain lipid-binding protein) (blbp) (mammary derived growth inhibitor related). [source:swissprot;acc:o15540]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2217\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat protein 4. [source:swissprot;acc:p57081]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2218\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myelin p2 protein. [source:swissprot;acc:p02689]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2219\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kelch-like protein 8. [source:swissprot;acc:q9p2g9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2220\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phenylethanolamine n-methyltransferase (ec 2.1.1.28) (pnmtase) (noradrenaline n-methyltransferase). [source:swissprot;acc:p11086]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2221\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-carotene dioxygenase 2; putative b,b-carotene-9',10'-dioxygenase. [source:refseq;acc:nm\_031938]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2222\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-carotene 15, 15'-dioxygenase; beta-carotene 15,15'-monooxygenase. [source:refseq;acc:nm\_017429]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2223\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid-binding protein, heart (h-fabp) (muscle fatty acid-binding protein) (m-fabp) (mammary-derived growth inhibitor) (mdgi). [source:swissprot;acc:p05413]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2224\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
retinal pigment epithelium-specific protein 65kda; retinal pigment epithelium-specific protein (65kd); retinitis pigmentosa 20 (autosomal recessive). [source:refseq;acc:nm\_000329]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/